+226.3%
CLSK vs GH
+363.0%
-136.8%
-71.3%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | GH | Excess | Alpha |
|---|---|---|---|---|
| 1D | +6.8% | -1.0% | +7.8% | +7.2% |
| 7D | +7.7% | -2.5% | +10.2% | +8.7% |
| 30D | +12.2% | -4.7% | +16.9% | +14.1% |
| 3M | -15.5% | +20.2% | -35.7% | -22.4% |
| 6M | +39.3% | +78.8% | -39.4% | +8.3% |
| YTD | +35.1% | +54.1% | -19.0% | +10.7% |
| 1Y | +34.0% | +177.1% | -143.1% | -15.6% |
| 3Y | +226.3% | +371.6% | -145.4% | +43.8% |
| All | +226.3% | +363.0% | -136.8% | +43.8% |
Cumulative growth
Daily Returns
Daily percentage return beside GH.
Daily Out/Under-Performance
Portfolio return minus GH return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GH return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded GH wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling